interferon
ifn
system
integr
compon
innat
immun
import
firstlin
defens
invad
virus
ifn
system
trigger
sensor
recogn
pathogenassoci
molecular
pattern
upon
ligand
bind
induc
signal
cascad
trigger
product
ifn
bind
ifn
ifn
receptor
induc
express
ifnstimul
gene
sever
encod
protein
antivir
activ
understand
antivir
effector
block
viral
spread
may
allow
devis
novel
antivir
strategi
thu
focu
mani
current
research
effort
famili
ifninduc
transmembran
protein
ifitm
compris
five
member
human
includ
antivir
activ
protein
protein
inhibit
host
cell
entri
driven
glycoprotein
mani
envelop
virus
includ
influenza
virus
fluav
coronavirus
filovirus
express
ifitm
block
entri
stage
glycoproteindriven
fusion
viral
cellular
membran
specif
hemifus
format
fusion
pore
blockad
might
due
ifitm
modifi
physic
properti
cellular
membran
potenti
via
ifitmifitm
interact
alter
membran
cholesterol
level
ifitmmedi
blockad
viral
entri
seem
restrict
larg
virus
enter
target
cell
via
fusion
endo
lysosom
membran
although
express
cell
surfac
thu
one
would
assum
entri
human
immunodefici
viru
hiv
simian
immunodefici
viru
siv
believ
proceed
mainli
plasma
membran
inhibit
laboratori
report
identif
ifitm
antivir
factor
inde
fail
detect
ifitmdepend
blockad
infect
nevertheless
subsequ
studi
report
ifitm
restrict
hiv
siv
entri
recent
report
ifitm
incorpor
progeni
hiv
siv
virion
ifitm
express
infect
cell
reduc
infect
progeni
virion
neg
impact
infect
might
due
ifitm
interact
env
result
reduc
env
process
incorpor
virion
howev
siv
sensit
ifitm
isol
specif
reason
isol
effici
inhibit
other
unknown
address
question
whether
determin
env
protein
could
impact
sensit
viral
entri
inhibit
ifitm
protein
scenario
might
account
least
part
strainspecif
differ
ifitm
sensit
discuss
might
explain
ifitm
sensit
hivsiv
entri
univers
observ
use
previous
describ
vector
system
allow
sensit
detect
viral
entri
robust
compar
express
ifitm
protein
transduc
cell
report
virion
context
viral
envelop
protein
present
well
effici
env
incorpor
particl
impact
sensit
ifitm
suggest
determin
control
inhibit
viral
entri
ifitm
complex
initi
appreci
first
ask
whether
natur
virion
viral
glycoprotein
present
impact
ifitmdepend
entri
inhibit
address
question
compar
ifitmmedi
inhibit
entri
driven
murin
leukemia
viru
env
mlvenv
simian
immunodefici
viru
env
sivenv
fluav
hemagglutininneuraminidas
fluavhana
present
context
retroviru
mlv
siv
rhabdoviru
vesicular
stomat
viru
vsv
base
vector
experi
target
cell
previous
transduc
express
ifitm
chloramphenicol
acetyltransferas
cat
neg
control
chosen
target
transduct
analysi
sivenvdepend
transduct
target
cell
addit
transfect
express
rhesu
macaqu
entri
mlv
siv
vector
pseudotyp
fluavhana
reduc
upon
express
mlvenvdriven
entri
bare
inhibit
ifitm
protein
expect
fig
similarli
entri
retrovir
particl
bear
sivenv
modestli
reduc
ifitm
protein
contrast
express
ifitm
protein
reduc
entri
vsv
vector
bear
mlvenv
sivenv
fluavha
least
mlvenv
sivenv
fluavha
fig
rel
suscept
inhibit
ifitm
protein
depend
amount
particl
use
transduct
shown
result
rais
question
whether
env
protein
present
vsv
vector
gener
suscept
inhibit
ifitm
protein
whether
factor
account
differenti
inhibit
instanc
reduc
ifitm
sensit
mlv
siv
vector
rel
vsv
vector
could
due
reduc
glycoprotein
incorpor
andor
gener
diminish
entri
effici
latter
might
increas
ifitm
sensit
howev
western
blot
analysi
sivenv
incorpor
mlv
siv
vsv
particl
point
toward
major
differ
fig
although
ratio
somewhat
higher
mlv
sivvsv
particl
shown
comparison
luciferas
valu
measur
lysat
transduc
cell
reveal
rel
sensit
ifitm
link
entri
effici
shown
altern
gene
express
vsv
mlv
siv
vector
might
inhibit
ifitm
address
use
vsv
minireplicon
system
depend
express
polymeras
cell
stabli
express
antivir
activ
ifitm
readili
visual
transduc
cell
transfect
control
cell
cell
stabli
express
plasmid
encod
minireplicon
system
yield
compar
signal
fig
indic
vsv
gene
express
inhibit
ifitm
moreov
transduct
cell
vsv
vector
bear
machupo
viru
glycoprotein
macvgpc
known
ifitm
insensit
slightli
inhibit
ifitm
similar
result
obtain
vector
bear
nipah
viru
glycoprotein
nivgf
fig
keep
concept
ifitm
block
vsv
gene
express
contrast
transduct
mediat
fluavha
strongli
block
express
fig
confirm
ifitm
protein
exert
antivir
activ
cell
line
test
collect
result
demonstr
ifitm
interfer
vsv
gene
express
find
compat
previou
studi
examin
sensit
intact
vsv
blockad
ifitm
protein
tetherin
consequ
one
must
postul
particl
context
viral
glycoprotein
present
impact
sensit
ifitm
vsvbase
vector
associ
higher
ifitm
sensit
retrovir
vector
next
use
simpl
twocompon
system
explor
potenti
impact
virion
background
ifitm
sensit
particl
base
hiv
gag
ebola
viru
ebov
protein
fuse
fragment
pseudotyp
vsvg
use
transduc
cell
stabli
express
addit
target
cell
transfect
express
fragment
vsvg
chosen
pseudotyp
gag
particl
glycoprotein
instanc
ebov
glycoprotein
ebovgp
hivenv
consist
yield
signal
background
vsvgdriven
entri
previous
shown
modestli
inhibit
find
confirm
present
studi
vsv
vector
fig
keep
find
vsvgdriven
entri
gag
particl
cell
express
reduc
rel
entri
control
cell
fig
contrast
express
appreci
impact
vsvgdriven
entri
particl
blockad
entri
less
effici
measur
gag
particl
fig
result
provid
evid
effici
inhibit
viral
entri
ifitm
depend
natur
virion
present
entrymedi
viral
glycoprotein
observ
siv
variant
differ
effici
env
incorpor
virion
sensit
ifitm
stimul
us
investig
whether
two
process
link
answer
question
produc
mlv
particl
cell
transfect
increas
amount
sivenv
mlvenvencod
plasmid
employ
condit
describ
fig
differ
amount
env
incorpor
virion
effect
ifitm
sensit
mlvenvdriven
entri
fig
similarli
previous
observ
effici
virion
incorpor
ebovgp
alter
sensit
ifitm
contrast
reduc
amount
sivenv
mlv
particl
markedli
increas
ifitm
sensit
concentrationdepend
manner
fig
effect
confirm
rhesu
macaquederiv
smagi
simian
multinuclear
activ
galactosidas
indic
cell
line
express
endogen
fig
small
interf
rna
sirna
mediat
knockdown
express
fig
markedli
increas
fluav
infect
expect
augment
effici
sivenvmedi
transduct
fig
latter
effect
invers
correl
effici
virion
incorpor
sivenv
fig
suggest
number
sivenv
trimer
present
virion
surfac
impact
sensit
ifitm
antivir
activ
play
import
role
defens
influenza
potenti
viral
diseas
thu
signific
interest
determin
full
rang
virus
suscept
inhibit
ifitm
well
establish
ifitm
target
host
cell
entri
sever
studi
employ
vector
system
determin
whether
viral
entri
block
ifitm
express
observ
sivenv
mlvenvdriven
entri
ifitm
sensit
glycoprotein
present
context
vsv
mlv
siv
particl
find
due
differenti
transduct
effici
major
differ
particl
incorpor
env
although
point
gagmprotein
level
directli
compar
minor
differ
particl
incorpor
effici
might
remain
undetect
similarli
observ
due
differenti
impact
ifitm
retrovir
rhabdovir
gene
express
unaffect
fig
data
shown
notabl
viruslik
particl
spheric
base
harbor
vsvg
exhibit
higher
sensit
toward
inhibit
correspond
particl
base
ebov
filament
appreci
differ
particl
incorpor
vsvg
observ
shown
therefor
one
must
postul
sensit
viral
glycoprotein
ifitm
depend
virion
context
specul
virion
differ
shape
might
exhibit
differ
propens
taken
cell
via
certain
uptak
mechan
thu
expos
ifitm
protein
consequ
studi
viral
vector
system
must
complement
examin
authent
virus
draw
firm
conclus
regard
ifitm
sensit
effici
ifitmmedi
inhibit
hiv
siv
entri
target
cell
isol
depend
present
unclear
reason
found
effici
sivenv
incorpor
envelop
mlv
vector
determin
degre
sensit
ifitm
find
suggest
differ
env
incorpor
could
contribut
differenti
ifitm
sensit
sivisol
contrast
amount
mlvenv
present
studi
ebovgp
insert
particl
modul
ifitm
sensit
discrep
observ
might
account
differenti
inhibit
glycoprotein
ifitm
thu
document
amphotericin
b
treatment
rescu
siv
ebovgpmedi
entri
blockad
ifitm
demonstr
ifitm
inde
interfer
viral
entri
via
differ
mechan
moreov
recent
demonstr
env
ifitm
interact
transfect
cell
shown
env
refer
rais
question
whether
interact
also
occur
entri
might
contribut
ifitmmedi
entri
blockad
case
increas
amount
sivenv
particl
envelop
might
allow
env
surpass
titer
ifitm
molecul
avail
inhibit
viral
entri
sum
identifi
novel
paramet
impact
sensit
viral
entri
ifitm
find
facilit
endeavor
fulli
defin
rang
virus
target
ifitm
could
help
understand
virus
might
evad
antivir
activ
protein
human
embryon
kidney
hek
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
lglutamin
penicillinstreptomycin
humidifi
atmospher
contain
cell
stabli
express
ifitm
protein
cat
well
smagi
simian
multinuclear
activ
galactosidas
indic
cell
previous
describ
also
grown
dmem
supplement
fc
antibiot
cell
line
express
vsvg
upon
mifepriston
treatment
kindli
provid
georg
herrler
also
describ
previous
previous
report
fluav
encod
gaussia
luciferas
use
plasmid
encod
glycoprotein
murin
leukemia
viru
mlvenv
fluav
strain
fluavha
neuraminidas
coexpress
particl
product
ensur
effici
particl
releas
vesicular
stomat
viru
vsvg
nipah
viru
nivf
nivg
machupo
viru
macvgpc
sivenv
describ
previous
mlvbase
vector
pqcxip
encod
ifitm
protein
cat
mlv
gagpolencod
plasmid
previous
describ
employ
express
ifitm
protein
cell
vector
mlvluc
sivbas
vector
luc
encod
firefli
luciferas
fluc
also
previous
report
use
quantifi
transduct
mediat
viral
glycoprotein
studi
plasmid
encod
ebov
gag
fuse
fragment
plasmid
encod
fragment
also
document
previous
vsv
minigenom
vsvmini
construct
follow
first
genet
inform
vsv
gene
enhanc
green
fluoresc
protein
egfp
excis
plasmid
modifi
vsv
genom
gene
flank
ident
restrict
site
conveni
clone
kindli
provid
gert
zimmer
make
use
avrii
nhei
restrict
site
nucleoprotein
rnadepend
rna
polymeras
open
read
frame
orf
respect
process
leader
trailer
sequenc
parent
vsv
genom
left
promot
end
hepat
delta
viru
ribozym
hdvr
termin
end
next
chimer
report
gene
consist
egfp
fluc
egfpfluc
fuse
via
linker
sequenc
ggg
ccc
gat
cct
cct
gtt
gct
act
gener
overlap
extens
pcr
ligat
leader
trailer
sequenc
yield
vsv
minigenom
posit
orient
gener
express
plasmid
vsvn
p
l
togeth
build
viral
polymeras
complex
respons
genom
replic
synthesi
subgenom
mrna
respect
orf
plasmid
amplifi
pcr
insert
pcagg
vector
restrict
digest
vsvn
ecorinhei
vsvp
ecorinhei
vsvl
nheinhei
ligat
pcramplifi
sequenc
verifi
autom
sequenc
product
retrovir
vector
encod
ifitm
protein
fluc
pseudotyp
viral
glycoprotein
describ
previous
brief
product
vector
encod
ifitm
protein
cell
cotransfect
plasmid
encod
mlv
gagpol
vsvg
pqcxip
code
ifitm
protein
cat
control
product
mlv
report
particl
cell
transfect
plasmid
encod
mlv
gagpol
viral
glycoprotein
studi
mlv
vector
code
fluc
similarli
siv
particl
produc
cotransfect
provir
plasmid
luc
contain
fluc
place
nef
gene
plasmid
encod
glycoprotein
interest
cultur
medium
exchang
h
posttransfect
supernat
harvest
h
posttransfect
supernat
steril
filter
filter
aliquot
store
prepar
luciferaseencod
vector
normal
compar
transduct
cell
usag
experi
product
vsv
particl
employ
replicationdefici
vsv
vector
vsv
contain
two
separ
orf
code
egfp
fluc
instead
genet
inform
vsvg
propag
previous
describ
vsvgexpress
transgen
cell
line
briefli
cell
transfect
calcium
phosphat
precipit
express
plasmid
encod
viral
surfac
protein
studi
h
posttransfect
cell
inocul
vsv
multipl
infect
moi
h
subsequ
cell
wash
final
receiv
fresh
cultur
medium
supplement
macvgpc
nivfg
fluavhana
mlvenv
sivenv
pseudotyp
vector
without
vsvg
pseudotyp
vector
neutral
antibodi
vsvg
hybridoma
supernat
atcc
addit
incub
period
h
vsv
pseudoparticlecontain
supernat
collect
clarifi
cell
debri
centrifug
aliquot
aliquot
store
maximum
day
order
analyz
ifitmmedi
inhibit
transduct
retrovir
vector
cell
seed
densiti
cell
per
well
plate
spinocul
g
min
ifitm
catencod
vector
altern
cell
stabli
express
ifitm
protein
cat
use
target
incub
cell
h
cultur
supernat
replac
fresh
cultur
medium
subsequ
cell
inocul
luciferasenorm
vector
harbor
viral
glycoprotein
studi
incub
h
thereaft
supernat
replac
fresh
cultur
medium
fluc
activ
cell
lysat
measur
h
postransduct
cell
cultur
supernat
remov
cell
wash
phosphatebuff
salin
pb
next
luciferas
cell
cultur
lysi
reagent
promega
pb
ad
well
well
incub
min
room
temperatur
cell
lysat
transfer
white
opaquewal
plate
thermo
scientif
measur
fluc
activ
carri
micropl
reader
plate
chameleon
v
hidex
use
softwar
version
mikrotek
laborsystem
gmbh
fluc
substrat
commerci
luciferas
assay
system
promega
beetlejuic
pjk
kit
transduct
effici
repres
fluc
activ
display
either
count
per
second
cp
normal
valu
analysi
ifitmmedi
inhibit
transduct
rhabdovir
vector
target
cell
prepar
describ
inocul
vsv
pseudotyp
h
afterward
cell
wash
incub
fresh
cultur
medium
h
follow
quantif
luciferas
activ
cell
lysat
describ
assess
vsv
genom
replic
plasmid
vsvmini
transfect
along
pcagg
plasmid
encod
vsvn
vsvp
vsvl
polymeras
kindli
provid
andrea
marzi
cell
line
stabli
express
ifitm
protein
cat
via
calcium
phosphat
precipit
upon
transfect
polymeras
synthes
crna
copi
minigenom
orient
authent
vsv
genom
context
viral
infect
copi
rna
serv
templat
genom
replic
synthesi
subgenom
mrna
depend
vsvn
p
l
howev
instead
synthesi
mrna
viral
protein
mrna
egfpfluc
synthes
h
posttransfect
medium
remov
fluc
activ
cell
lysat
quantifi
describ
knock
ifitm
express
smagi
cell
cell
per
well
seed
plate
transfect
sirna
direct
santa
cruz
scrambl
sequenc
use
lipofectamin
rnaimax
invitrogen
transfect
reagent
accord
manufactur
protocol
h
posttransfect
medium
replac
fresh
dmem
cell
transduc
mlv
vector
encod
luciferas
pseudotyp
sivenv
parallel
express
analyz
describ
luciferas
activ
cell
lysat
analyz
h
posttransduct
describ
parallel
cell
inocul
gaussia
luciferaseencod
influenza
viru
moi
input
viru
remov
wash
luciferas
activ
cell
supernat
determin
h
postinfect
analysi
sivenv
gag
vsvm
incorpor
retro
rhabdovir
particl
respect
particl
purifi
via
ultracentrifug
sucros
cushion
pellet
resuspend
sdspage
sampl
buffer
analyz
western
blot
mlvgag
detect
use
mous
antibodi
acri
sivgag
detect
use
mous
antibodi
vsvm
detect
perform
use
antivsvm
antibodi
kerafast
sivenv
detect
use
mous
monoclon
antibodi
recogn
epitop
within
horseradish
peroxidas
hrp
coupl
goat
antimous
igg
hl
antibodi
dianova
use
detect
employ
commerci
avail
kit
amersham
analyz
ifitm
express
smagi
cell
antibodi
use
proteintech
